{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:32:14Z","timestamp":1789824734315,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1053\/j.ajkd.2012.06.022","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T05:31:32Z","timestamp":1344490292000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD"],"prefix":"10.1053","volume":"61","author":[{"given":"Kelsey","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"deFilippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Laliberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Seliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Show-Hong","family":"Duh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Christenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1053\/j.ajkd.2012.06.022_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2012.06.022_bib2","first-page":"e1","article-title":"USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"59","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.V1251079","article-title":"Left ventricular hypertrophy in the renal patient","volume":"12","author":"Middleton","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.06.022_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.ajkd.2012.06.022_bib5","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ajkd.2012.06.022_bib6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.022_bib7","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.06.022_bib8","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1053\/j.ajkd.2012.06.022_bib10","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1053\/j.ajkd.2012.06.022_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.022_bib13","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1053\/j.ajkd.2012.06.022_bib14","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0735-1097(02)02608-6","article-title":"Cardiac troponins in renal insufficiency: review and clinical implications","volume":"40","author":"Freda","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1053\/j.ajkd.2012.06.022_bib15","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"issue":"16","key":"10.1053\/j.ajkd.2012.06.022_bib16","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.105.609974","article-title":"Prevalence and determinants of troponin T elevation in the general population","volume":"113","author":"Wallace","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib17","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1378\/chest.125.5.1877","article-title":"Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance","volume":"125","author":"Roongsritong","year":"2004","journal-title":"Chest"},{"issue":"26","key":"10.1053\/j.ajkd.2012.06.022_bib18","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.ajkd.2012.06.022_bib19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.022_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/eurjhf\/hfp072","article-title":"Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure","volume":"11","author":"Tsutamoto","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfr316","article-title":"FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4","volume":"27","author":"Ford","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2012.06.022_bib22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1681\/ASN.2008010012","article-title":"Use of cardiac biomarkers in end-stage renal disease","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2012.06.022_bib23","first-page":"155A","article-title":"A simplified equation to predict glomerular filtration rate from serum creatinine (abstract)","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.022_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","article-title":"Analytical validation of a high-sensitivity cardiac troponin T assay","volume":"56","author":"Giannitsis","year":"2010","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ndt\/gfq442","article-title":"Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay","volume":"26","author":"Kumar","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2012.06.022_bib27","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/ndt\/gfi125","article-title":"Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis","volume":"20","author":"Conway","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.022_bib28","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2215\/CJN.04290511","article-title":"Fibroblast growth factor 23 in patients undergoing peritoneal dialysis","volume":"6","author":"Isakova","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.022_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.022_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.022_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/clinchem\/47.3.412","article-title":"Cardiac troponin T predicts long-term outcomes in hemodialysis patients","volume":"47","author":"Ooi","year":"2001","journal-title":"Clin Chem"},{"issue":"16","key":"10.1053\/j.ajkd.2012.06.022_bib32","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/01.CIR.102.16.1964","article-title":"Cardiac troponin T predicts mortality in patients with end-stage renal disease","volume":"102","author":"Dierkes","year":"2000","journal-title":"Circulation"},{"issue":"20","key":"10.1053\/j.ajkd.2012.06.022_bib33","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1161\/CIRCULATIONAHA.105.560128","article-title":"Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis","volume":"112","author":"Khan","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.022_bib34","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1373\/clinchem.2005.055665","article-title":"Cardiac troponins and renal function in nondialysis patients with chronic kidney disease","volume":"51","author":"Abbas","year":"2005","journal-title":"Clin Chem"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1373\/clinchem.2006.078378","article-title":"Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients","volume":"53","author":"Wang","year":"2007","journal-title":"Clin Chem"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.022_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"deFilippi","year":"2003","journal-title":"JAMA"},{"issue":"23","key":"10.1053\/j.ajkd.2012.06.022_bib37","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000041254.30637.34","article-title":"Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease","volume":"106","author":"Apple","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.022_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/ajkd.2002.33914","article-title":"Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"40","author":"Mallamaci","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.ajkd.2003.12.048","article-title":"Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk","volume":"43","author":"Goicoechea","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.022_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/46.3.338","article-title":"Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology","volume":"46","author":"Ooi","year":"2000","journal-title":"Clin Chem"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(97)70156-X","article-title":"Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T","volume":"133","author":"Antman","year":"1997","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.022_bib42","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ndt\/16.7.1452","article-title":"Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study","volume":"16","author":"Iliou","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.022_bib43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ndt\/gfh741","article-title":"Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients","volume":"20","author":"Duman","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.022_bib44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ahj.2011.07.016","article-title":"Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce Cardiovascular Events With Aranesp (darbepoetin-alfa) Therapy (TREAT)","volume":"162","author":"McMurray","year":"2011","journal-title":"Am Heart J"},{"issue":"12","key":"10.1053\/j.ajkd.2012.06.022_bib45","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1253\/circj.CJ-10-0355","article-title":"Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients","volume":"74","author":"Negishi","year":"2010","journal-title":"Circ J"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.022_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1542-4758.2011.00630.x","article-title":"FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients","volume":"16","author":"Holden","year":"2012","journal-title":"Hemodial Int"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2012.06.022_bib47","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.3346\/jkms.2009.24.S1.S109","article-title":"Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients","volume":"24","author":"Hur","year":"2009","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.022_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2215\/CJN.10030911","article-title":"Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23","volume":"7","author":"Burnett-Bowie","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.022_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612009523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612009523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:59:53Z","timestamp":1759456793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612009523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0272638612009523"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.06.022","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}